Enzymatic anticancer therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/50 (2006.01) A61P 35/00 (2006.01) C12N 9/78 (2006.01)

Patent

CA 2684749

What is provided is a method of treating a patient having a tumor comprising administering an effective amount of adenosine deaminase, preferably polyalkylene oxide conjugated, to a patient in need thereof.

L'invention propose un procédé de traitement d'un patient ayant une tumeur qui comprend l'administration, à un patient en ayant besoin, d'une quantité efficace d'adénosine désaminase, de préférence un oxyde de polyalkylène conjugué.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enzymatic anticancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enzymatic anticancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enzymatic anticancer therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1574317

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.